Cite
MLA Citation
A.J. Davies et al.. “ARGO: A RANDOMISED PHASE II STUDY OF ATEZOLIZUMAB WITH RITUXIMAB, GEMCITABINE AND OXALIPLATIN IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA WHO ARE NOT CANDIDATES FOR HIGH‐DOSE THERAPY.” Hematological oncology, vol. 37, n.d., pp. 555–556. http://access.bl.uk/ark:/81055/vdc_100086192161.0x000046